CVS blows past estimates, hikes guidance as insurance unit continues to improve

CVS Health beat Wall Street estimates in its second-quarter results and raised its full-year outlook, per CNBC, as its insurance business showed continued improvement. The company also announced a new partnership with Eli Lilly to make the weight-loss drugs Zepbound and Foundayo available to eligible patients through the CVS Health app.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton